All In Biotech

Drug Trial Radar · NCT05229965

Paracetamol Vs Caffeine Vs Codeine in the Management of Post Traumatic Pain in Emergencies

Paracetamol Vs Paracetamol-Caffeine Association Vs Paracetamol-Codeine Association in the Management of Post Traumatic Pain in Emergencies

Last checked: Nov 20, 2026Latest source record: Jun 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,500

Actual

Start

Nov 1, 2022

Primary completion

Jun 27, 2023

Study completion Jun 27, 2023

Sponsor

Lead sponsor
University of MonastirAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to: Compare the effect of paracetamol alone against Paracetamol+Codeine association against the association of paracetamol + Cafeine in the treatment of post-traumatic acute pain of the limbs.

Conditions

  • Acute Pain Due to Trauma

Interventions

  • ParacetamolDrug

    21 pills will be provided with a preconised dose of 1 pill 3 times per day over 7 days period

  • Paracetamol CodeineDrug

    14 pills will be provided with a preconised dose of 1 pill 2 times per day over 7 days period

  • Paracetamol caféineDrug

    21 pills will be provided with a preconised dose of 1 pill 3 times per day over 7 days period

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Delta Numerical Rating Scale (NRS) ( From 0 to 10 )Time frame: 7 days from discharge

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nouira Semir

    Monastir, Tunisia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.